The [tag]Senate[/tag] begins debate today on three bills on [tag]stem-cell[/tag] [tag]research[/tag], all of which are expected to pass tomorrow, despite a veto threat from the Bush White House on the main proposal to undo the president’s 2001 restrictions. As the debate gets underway, be sure to look out for one of the right’s favorite talking points, which had been thoroughly debunked.
For example, Sen. Sam [tag]Brownback[/tag] (R-Kan.), a leading opponent of stem-cell research, argued two weeks ago that researchers have “derived over 70 peer-reviewed and published medical treatments from adult stem cell research.” Similarly, Tony Perkins, president of the conservative Family Research Council, said last week that embryonic stem-cell research is unnecessary because adult stem-cell research “has produced results for over 70 different medical conditions.”
Brownback, Perkins, and other leading conservatives have used this talking point repeatedly, relying on the work of [tag]David Prentice[/tag], a scientist with Perkins’ Family Research Council. Unfortunately for the right, Prentice’s work doesn’t withstand scrutiny. Late last week, the journal Science published a letter by three researchers documenting significant errors in the FRC researcher’s results.
“Prentice not only misrepresents existing adult stem cell treatments but also frequently distorts the nature and content of the references he cites,” wrote Shane Smith of the Children’s Neurobiological Solutions Foundation in Santa Barbara, Calif.; William B. Neaves of the Stowers Institute for Medical Research in Kansas City, Mo.; and Steven Teitelbaum of Washington University in St. Louis.
For example, they wrote, a study cited by Prentice as evidence that adult stem cells can help patients with testicular cancer is in fact a study that evaluates methods of isolating adult stem cells.
Prentice is frequently seen walking around Congress — he’s a top Brownback advisor on stem-cell policy — carrying a binder filled with his evidence on adult stem cells. Nearly all of them are wrong. As the WaPo noted, there are only nine diseases that have been proved to respond to treatment with adult stem cells, about one-eighth the number Prentice has argued.
Bogus evidence aside, the Senate debate should get pretty interesting.
Under Senate procedure on the bill, the main stem-cell legislation, which already passed the House with bi-partisan support, will need 60 votes to pass. Recent head-counts suggest that proponents will have the votes to advance the bill to the [tag]White House[/tag], where it’s likely to become the first [tag]veto[/tag] of [tag]Bush[/tag]’s presidency.
It’s also worth noting that the Senate will be taking up three bills relating to stem-cell research, not one. In addition to the principal legislation that’s drawing the bulk of the attention, [tag]conservatives[/tag] have created two more proposals.
One of the alternate bills would ban the non-existent practice of “fetal farming” — removing embryos from women’s wombs for medical research. The other, sponsored by Sen. Sam Brownback, R-Kan., would mandate that the National Institutes of Health focus its research dollars on cures from adult stem cells.
The “[tag]fetal farming[/tag]” bill is of particular interest because it outlaws the trade of tissue produced by pregnancies that are aborted specifically to harvest the tissue for medical research. Does “fetal farming” exist? No. Is anyone, anywhere, seriously advocating for such a practice? No. But the right, true to form, wants to tackle the “problem” anyway, just in case.
The Senate will likely hold a floor vote tomorrow afternoon. Stay tuned.